Skip to main content
MEHA
OTC Life Sciences

Functional Brands Q2 Loss Widens to $2.6M; Going Concern Doubt Persists

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$0.005
Mkt Cap
$204.574K
52W Low
$0.004
52W High
$8
52W Position info
21% above low
Off High info
100% below high
Rel. Volume
Market data snapshot near publication time

MEHA sits 21% above its 52-week low of $0.004.

Summary

Functional Brands reported a $2.6M Q2 net loss, up from $0.2M a year ago, with going concern doubt reiterated. The BullionFX deal was terminated and the stock now trades on OTC Markets.


Key Events · Earnings and Guidance · MEHA

  • Q2 Net Loss Widens to $2.6M

    Net loss increased from $0.2M to $2.6M year-over-year, driven by higher G&A expenses and a $968K non-cash derivative liability charge.

  • Going Concern Doubt Reiterated

    Cash of $352K, working capital deficit of $2.9M, and accumulated deficit of $16.7M raise substantial doubt about the company's ability to continue as a going concern.

  • BullionFX Acquisition Terminated

    BullionFX terminated the binding letter of intent on June 29, 2026, removing a potential strategic alternative for the company.

  • Nasdaq Delisting Completed

    The company's common stock was delisted from Nasdaq and now trades on OTC Markets under ticker MEHA, limiting access to capital markets.


Analysis · MEHA · Life Sciences

The second quarter results reveal a sharp deterioration in profitability, with net loss expanding from $0.2M to $2.6M year-over-year. Revenue grew modestly and gross margin improved, but operating expenses more than doubled, driven by public-company costs and professional fees. The balance sheet remains under severe stress: cash of only $352K, a working capital deficit of $2.9M, and an accumulated deficit of $16.7M. Management explicitly reiterates substantial doubt about the company's ability to continue as a going concern. The termination of the BullionFX acquisition removes a potential strategic lifeline, and the Nasdaq delisting further limits capital-raising options. This filing confirms the company is in a precarious financial position with no clear path to stability.

At the time of this filing, MEHA was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $204.6K. The 52-week trading range was $0.00 to $8.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEHA - Latest Insights

MEHA
Aug 14, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
MEHA
Jul 02, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
MEHA
Jun 30, 2026, 6:46 PM EDT
Filing Type: 8-K
Importance Score:
10
MEHA
Jun 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
MEHA
Jun 15, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
10